Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges

Npj Regenerative Medicine
Mahetab H AmerLisa J White

Abstract

Significant progress has been made during the past decade towards the clinical adoption of cell-based therapeutics. However, existing cell-delivery approaches have shown limited success, with numerous studies showing fewer than 5% of injected cells persisting at the site of injection within days of transplantation. Although consideration is being increasingly given to clinical trial design, little emphasis has been given to tools and protocols used to administer cells. The different behaviours of various cell types, dosing accuracy, precise delivery, and cell retention and viability post-injection are some of the obstacles facing clinical translation. For efficient injectable cell transplantation, accurate characterisation of cellular health post-injection and the development of standardised administration protocols are required. This review provides an overview of the challenges facing effective delivery of cell therapies, examines key studies that have been carried out to investigate injectable cell delivery, and outlines opportunities for translating these findings into more effective cell-therapy interventions.

References

Jul 1, 1977·Circulation Research·S P Sutera
Dec 11, 1999·JAMA : the Journal of the American Medical Association·A M MalekS Izumo
Mar 10, 2001·The New England Journal of Medicine·C R FreedS Fahn
Oct 3, 2001·Nature Biotechnology·M J Mahoney, W M Saltzman
Feb 20, 2002·Journal of Molecular and Cellular Cardiology·Jochen Müller-EhmsenLarry Kedes
Oct 29, 2002·Annals of Neurology·Yilong MaDavid Eidelberg
Jul 2, 2003·Biomaterials·Hyun Joon KongDavid J Mooney
Sep 4, 2003·Annals of Neurology·C Warren OlanowThomas B Freeman
Feb 5, 2005·Cell Transplantation·Douglas KondziolkaMichael McGrogan
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Olle Lindvall, Anders Björklund
Jul 5, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Hao WangChangyi Chen
Aug 27, 2005·Journal of Neurosurgery·Douglas KondziolkaJeffrey Teraoka
Oct 13, 2005·Brain : a Journal of Neurology·F FéronA Mackay-Sim
Mar 31, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Soheila Karimi-AbdolrezaeeMichael G Fehlings
Oct 12, 2007·Biotechnology and Bioengineering·Farlan S VeraitchChris Mason
Mar 8, 2008·Medical & Biological Engineering & Computing·Robert S Reneman, Arnold P G Hoeks
Jun 17, 2008·Transplantation Proceedings·T MehtaH Trivedi
Aug 12, 2008·Brain : a Journal of Neurology·A Mackay-SimT Geraghty
Aug 13, 2008·The Journal of Surgical Research·Matthew T HartingCharles S Cox
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eduardo A SilvaDavid J Mooney
Dec 6, 2008·Current Opinion in Urology·Allison M Okamura
Dec 25, 2008·Regenerative Medicine·Kapil AgashiKevin M Shakesheff
Feb 7, 2009·Biotechnology Progress·Sarah Stolberg, Kara E McCloskey
Mar 14, 2009·Journal of Tissue Engineering and Regenerative Medicine·Maritie GrellierJoëlle Amédée
Jul 4, 2009·Biotechnology and Bioengineering·Timm TanzeglockMassimo Morbidelli
Aug 12, 2009·Clinical Ophthalmology·Jean Pierre HubschmanSteven D Schwartz

❮ Previous
Next ❯

Citations

Jul 5, 2018·International Journal of Molecular Sciences·Fabien NativelGael Grimandi
Nov 18, 2018·British Journal of Pharmacology·K F BruggemanC L Parish
Oct 9, 2019·Aging Clinical and Experimental Research·Anna TampieriSimone Sprio
Oct 18, 2019·Biomaterials Science·Daniela BarrosAna P Pêgo
Nov 30, 2018·Journal of Molecular Neuroscience : MN·Saeed FarzamfarHamed Sahrapeyma
Oct 29, 2019·Stroke; a Journal of Cerebral Circulation·Johannes BoltzeUNKNOWN STEPS 4 Consortium
Jul 6, 2019·Acta neurochirurgica·David Satzer, Peter C Warnke
Sep 29, 2019·Journal of Cellular and Molecular Medicine·Leyla Fath-BayatiEhsan Sharif-Paghaleh
Dec 20, 2018·Advanced Materials·Nureddin AshammakhiAli Khademhosseini
Oct 10, 2020·Scientific Reports·Marbod WeberMeltem Avci-Adali
Jan 5, 2021·Frontiers in Cell and Developmental Biology·Yu-Jie LinChieh-Cheng Huang
Sep 11, 2019·Materials Science & Engineering. C, Materials for Biological Applications·Joana LoureiroIsabel Freitas Amaral
Dec 22, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kyungsook KimTeruo Okano
Aug 21, 2020·The Journal of Clinical Investigation·Jinmin LeeAimee S Payne
Mar 31, 2021·Npj Regenerative Medicine·Andrea De PieriDimitrios I Zeugolis
May 1, 2021·ACS Biomaterials Science & Engineering·Shixuan ChenJingwei Xie
May 1, 2021·International Journal of Molecular Sciences·Marina DanalacheWilhelm K Aicher
May 4, 2021·Chemical Reviews·Santiago CorreaEric A Appel
May 31, 2021·Cytotherapy·Anqi LiRebecca Lim
Jul 3, 2021·International Journal of Molecular Sciences·Jörg SchmehlStefanie Elser
Jul 3, 2021·International Journal of Molecular Sciences·Walter LinzenboldMarkus D Enderle
Aug 8, 2021·Cells·Hareklea MarkidesAlicia J El Haj
May 13, 2019·ACS Biomaterials Science & Engineering·James D TangKyle J Lampe
Sep 19, 2021·Advanced Healthcare Materials·Xiaojie LinMiqin Zhang
Nov 23, 2021·Advanced Healthcare Materials·Rebecca D Bierman-DuquetteStephanie K Seidlits

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.